logo conference-reports

Kongressrapporter

Educational funding by logo MSD Oncology

ESTRO 2019 – Expert commentary : Combining immune checkpoint inhibitors with radiotherapy: present and future

The potential for combining RT with immunotherapy is enormous, yet combination therapies still have a long way to go before entering into routine clinical practice
Tjenesten du prøver å få tilgang til er bare tilgjengelig for registrerte brukere. For å fortsette vennligst logg inn eller registrer deg for en gratis konto på Univadis